Mechanistically, DCAF15 inhibition was associated with upregulated expression of the co-stimulatory molecule CD8054; DCAF15 inhibition was also shown to disrupt alternative splicing in cancer cells and generates neoantigens, which stimulate T cell-mediated clearance.55 Here, DCAF15 is linked to cancer.